Pharmaceutical preparation comprising EPO for the treatment of FriedreichÆs ataxia

摘要

Disclosed is the use of human erythropoietin or a derivative thereof having the biological activity of human erythropoietin of increasing the expression of frataxin for the production of a pharmaceutical preparation for the treatment of Friedreich's ataxia or a disease associated therewith in a patient suffering from Friedreich's ataxia.